Vyne Therapeutics Stock Cycle Indicators Hilbert Transform Dominant Cycle Period

VYNE Stock  USD 2.89  0.06  2.03%   
Vyne Therapeutics cycle indicators tool provides the execution environment for running the Hilbert Transform Dominant Cycle Period indicator and other technical functions against Vyne Therapeutics. Vyne Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Dominant Cycle Period indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of Vyne Therapeutics price series.

Indicator
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The Hilbert Transform - Dominant Cycle Period indicator is used to generate in-phase and quadrature components of Vyne Therapeutics price series in order to analyze variations of the instantaneous cycles.

Vyne Therapeutics Technical Analysis Modules

Most technical analysis of Vyne Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vyne from various momentum indicators to cycle indicators. When you analyze Vyne charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Vyne Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vyne Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vyne Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Vyne Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vyne Therapeutics's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Vyne Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Vyne Therapeutics, we also check how macroeconomic factors affect Vyne Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2020 2021 2023 2024 (projected)
Payables Turnover0.290.510.460.24
Days Of Inventory On Hand1.9K794.87914.11.5K
Hype
Prediction
LowEstimatedHigh
0.152.987.39
Details
Intrinsic
Valuation
LowRealHigh
1.776.1810.59
Details
3 Analysts
Consensus
LowTargetHigh
15.0216.5018.32
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.23-0.15-0.02
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Vyne Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Vyne Therapeutics' short interest history, or implied volatility extrapolated from Vyne Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Entertainment Idea
Entertainment
Invested over 90 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 60 shares
Business Services Idea
Business Services
Invested over 100 shares
Banking Idea
Banking
Invested over 20 shares
FinTech Idea
FinTech
Invested over 40 shares
Video Games Idea
Video Games
Invested few shares
Cash Cows Idea
Cash Cows
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 30 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Manufacturing Idea
Manufacturing
Invested over 30 shares
Investor Favorites Idea
Investor Favorites
Invested over 60 shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
When determining whether Vyne Therapeutics is a strong investment it is important to analyze Vyne Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vyne Therapeutics' future performance. For an informed investment choice regarding Vyne Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vyne Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Vyne Stock refer to our How to Trade Vyne Stock guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vyne Therapeutics. If investors know Vyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vyne Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
1.72
Revenue Per Share
0.016
Quarterly Revenue Growth
0.467
Return On Assets
(0.35)
Return On Equity
(0.60)
The market value of Vyne Therapeutics is measured differently than its book value, which is the value of Vyne that is recorded on the company's balance sheet. Investors also form their own opinion of Vyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vyne Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vyne Therapeutics' market value can be influenced by many factors that don't directly affect Vyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vyne Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vyne Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vyne Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.